TYROSINE PROTEIN-KINASE ACTIVITY OF HUMAN HYPERPLASTIC PROSTATE AND CARCINOMA CELL-LINES PC3 AND DU145

被引：0
|
作者：
DUROCHER, Y
CHAPDELAINE, A
CHEVALIER, S
机构：
[1] MAISONNEUVE ROSEMONT MED CTR,5415 ASSOMPT BLVD,MONTREAL H1T 2M4,QUEBEC,CANADA
[2] UNIV MONTREAL,MONTREAL H1T 2M4,QUEBEC,CANADA
来源：
CANCER RESEARCH | 1989年 / 49卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4818 / 4823
页数：6
相关论文
共 50 条
  • [31] The Role of SIRT1 in Chemoresistance of Prostate Cancer PC3 and DU145 Cells by A Novel Anthraquinone Derivatives
    Hsu, Chin-Chia
    Hsu, Hsue-Yin
    CANCER SCIENCE, 2018, 109 : 1074 - 1074
  • [32] Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells
    Fu, Ya-Min
    Yu, Zu-Xi
    Lin, Huimin
    Fu, Xing
    Meadows, Gary G.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 217 (01) : 184 - 193
  • [33] Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells
    Tian, Hua
    Zhou, Yan
    Yang, Gaoxiang
    Geng, Yang
    Wu, Sai
    Hu, Yabin
    Lin, Kai
    Wu, Wei
    ONCOLOGY REPORTS, 2016, 36 (03) : 1361 - 1368
  • [34] Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo
    Alsulaiman, Mona
    Bais, Manish V.
    Trackman, Philip C.
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2016, 10 (01) : 17 - 31
  • [35] Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo
    Mona Alsulaiman
    Manish V. Bais
    Philip C. Trackman
    Journal of Cell Communication and Signaling, 2016, 10 : 17 - 31
  • [36] New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145
    Jones, HE
    Dutkowski, CM
    Barrow, D
    Harper, ME
    Wakeling, AE
    Nicholson, RJ
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (06) : 1010 - 1018
  • [37] Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells
    Jin, Yena
    Kim, Young Hwan
    Park, Jin Yong
    Lee, Yu-Jin
    Oh, Hyun-Mi
    Choi, Sung-Kyu
    Han, Dong Cho
    Kwon, Byoung-Mog
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 853 - 857
  • [38] A Rare, Human Prostate Oncocyte Cell Originates from the Prostatic Carcinoma (DU145) Cell Line
    Gilloteaux, Jacques
    Eze, Nkechinyere
    Jamison, James M.
    McGuire, Karen
    Summers, Jack L.
    ULTRASTRUCTURAL PATHOLOGY, 2013, 37 (06) : 440 - 448
  • [39] Selective restriction of amino acid interferes with Raf and Akt survival pathways in DU145 and PC3 prostate cancer cells
    Fu, Ya-Min
    Zhang, Hui
    Ding, Mingjie
    Li, Yi-Qi
    Fu, Xing
    Meadows, Gary G.
    CANCER RESEARCH, 2006, 66 (08)
  • [40] Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145
    McPherson, SJ
    Thomas, TZ
    Wang, H
    Gurusinghe, CJ
    Risbridger, GP
    JOURNAL OF ENDOCRINOLOGY, 1997, 154 (03) : 535 - 545
12345